Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors

被引:229
|
作者
Wang, Jianbin [1 ]
Exline, Colin M. [2 ]
DeClercq, Joshua J. [1 ]
Llewellyn, G. Nicholas [2 ]
Hayward, Samuel B. [1 ]
Li, Patrick Wai-Lun [1 ]
Shivak, David A. [1 ]
Surosky, Richard T. [1 ]
Gregory, Philip D. [1 ]
Holmes, Michael C. [1 ]
Cannon, Paula M. [2 ]
机构
[1] Sangamo BioSci Inc, Richmond, CA USA
[2] Univ So Calif, Keck Sch Med, Dept Mol Microbiol, Los Angeles, CA 90033 USA
基金
美国国家卫生研究院;
关键词
TARGETED GENE ADDITION; ZINC-FINGER NUCLEASES; ADENOASSOCIATED VIRUS VECTORS; STRAND BREAK REPAIR; LENTIVIRAL VECTOR; LONG-TERM; T-CELLS; IN-VIVO; DNA; CCR5;
D O I
10.1038/nbt.3408
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Genome editing with targeted nucleases and DNA donor templates homologous to the break site has proven challenging in human hematopoietic stem and progenitor cells (HSPCs), and particularly in the most primitive, long-term repopulating cell population. Here we report that combining electroporation of zinc finger nuclease (ZFN) mRNA with donor template delivery by adeno-associated virus (AAV) serotype 6 vectors directs efficient genome editing in HSPCs, achieving site-specific insertion of a GFP cassette at the CCR5 and AAVS1 loci in mobilized peripheral blood CD34(+) HSPCs at mean frequencies of 17% and 26%, respectively, and in fetal liver HSPCs at 19% and 43%, respectively. Notably, this approach modified the CD34(+)CD133(+)CD90(+) cell population, a minor component of CD34(+) cells that contains long-term repopulating hematopoietic stem cells (HSCs). Genome-edited HSPCs also engrafted in immune-deficient mice long-term, confirming that HSCs are targeted by this approach. Our results provide a strategy for more robust application of genome-editing technologies in HSPCs.
引用
收藏
页码:1256 / +
页数:10
相关论文
共 50 条
  • [31] Efficient GMP-compatible CRISPR-Cas mediated genome editing in hematopoietic stem and progenitor cells
    Turchiano, G.
    Haas, S.
    Hildenbeutel, M.
    Pennucci, V.
    Cornu, T. I.
    Cathomen, T.
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2017, 44 : 81 - 81
  • [32] TALEN-mediated genome editing via AAV6 donor in T cells for the treatment of X-linked lymphoproliferative disease (XLP)
    Houghton, B. C.
    Mussolino, C.
    Cathomen, T.
    Gaspar, H. B.
    Thrasher, A. J.
    Booth, C.
    HUMAN GENE THERAPY, 2017, 28 (12) : A52 - A52
  • [33] CD34+cells from dental pulp stem cells with a ZFN-mediated and homology-driven repair-mediated locus-specific knock-in of an artificial β-globin gene
    Chattong, S.
    Ruangwattanasuk, O.
    Yindeedej, W.
    Setpakdee, A.
    Manotham, K.
    GENE THERAPY, 2017, 24 (07) : 425 - 432
  • [34] Primary Human CD34+ Hematopoietic Stem/Progenitor Cell (HSPC) Transduction By AAV6 Serotype Vectors: Strategies for Overcoming the Donor-Variation
    Yin, Zifei
    Aslanidi, George V.
    Ling, Chen
    Zhang, Yuanhui
    Ling, Changquan
    Tan, Mengqun
    Yoder, Mervin C.
    Srivastava, Arun
    MOLECULAR THERAPY, 2015, 23 : S220 - S221
  • [35] CD34+ cells from dental pulp stem cells with a ZFN-mediated and homology-driven repair-mediated locus-specific knock-in of an artificial β-globin gene
    S Chattong
    O Ruangwattanasuk
    W Yindeedej
    A Setpakdee
    K Manotham
    Gene Therapy, 2017, 24 : 425 - 432
  • [36] Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination
    Martin, Renata M.
    Ikeda, Kazuya
    Cromer, M. Kyle
    Uchida, Nobuko
    Nishimura, Toshinobu
    Romano, Rosa
    Tong, Andrew J.
    Lemgart, Viktor T.
    Camarena, Joab
    Pavel-Dinu, Mara
    Sindhu, Camille
    Wiebking, Volker
    Vaidyanathan, Sriram
    Dever, Daniel P.
    Bak, Rasmus O.
    Laustsen, Anders
    Lesch, Benjamin J.
    Jakobsen, Martin R.
    Sebastiano, Vittorio
    Nakauchi, Hiromitsu
    Porteus, Matthew H.
    CELL STEM CELL, 2019, 24 (05) : 821 - +
  • [37] Correction of SCID-X1 by targeted genome editing of hematopoietic stem/progenitor cells (HSPC) in the mouse model
    Schiroli, G.
    Genovese, P.
    Capo, V.
    Castiello, M. C.
    Albano, L.
    Sanvito, F.
    Holmes, M. C.
    Villa, A.
    Sitia, G.
    Lombardo, A.
    Naldini, L.
    HUMAN GENE THERAPY, 2016, 27 (11) : A135 - A136
  • [38] Double Strand Break Free Genome Editing to Target Hematopoietic Stem and Progenitor Cells: Therapeutic Applicability in Fanconi Anemia
    Ugalde, Laura
    Karasu, Erman
    Siegner, Sebastian
    Garcia, Laura
    Clemens, Alexandra
    Olalla, Beatriz
    Alvarez, Lara
    Pena, Irene
    Bueren, Juan A.
    Corn, Jacob
    Rio, Paula
    MOLECULAR THERAPY, 2022, 30 (04) : 4 - 5
  • [39] Correction of SCID-X1 by Targeted Genome Editing of Hematopoietic Stem/Progenitor Cells (HSPC) in the Mouse Model
    Schiroli, Giulia
    Genovese, Pietro
    Capo, Valentina
    Castiello, Maria C.
    Albano, Luisa
    Holmes, Michael C.
    Villa, Anna
    Sitia, Giovanni
    Lombardo, Angelo
    Naldini, Luigi
    MOLECULAR THERAPY, 2016, 24 : S18 - S19
  • [40] ZFN-Driven Gene Editing Prevents HLA-A Expression On Hematopoietic Stem Cells -Improving The Chance Of Finding An HLA-Matched Donor
    Torikai, Hiroki
    Mi, Tiejuan
    Ang, Sonny O.
    Gragert, Loren
    Maiers, Martin
    Maiti, Sourindra
    Switzer, Kirsten
    Huls, Helen
    Reik, Andreas
    Holmes, Michael C.
    Gregory, Philip D.
    Champlin, Richard E.
    Shpall, Elizabeth J.
    Cooper, Laurence J. N.
    BLOOD, 2013, 122 (21)